This information is intended for Colorado Prescribers
HB 19-1131
| MARKETED PRESCRIPTION DRUG | COLORADO WAC DISCLOSURE FORM | DATE UPDATED |
|---|---|---|
| ActHIB® Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) | Form | 8/2/2019 |
| Adacel® Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed | Form | 8/2/2019 |
| Adlyxin® (lixisenatide) | Form | 8/2/2019 |
| ADMELOG® (insulin lispro injection) | Form | 8/2/2019 |
| ALDURAZYME® (laronidase) | Form | 8/2/2019 |
| Alprolix® [Coagulation Factor IX (Recombinant), Fc Fusion Protein] | Form | 8/2/2019 |
| APIDRA® (insulin glulisine injection) | Form | 8/2/2019 |
| AUBAGIO® (teriflunomide) | Form | 8/2/2019 |
| Avalide® (irbesartan-hydrochlorothiazide) | Form | 8/2/2019 |
| Avapro® (irbesartan) | Form | 8/2/2019 |
| Cablivi® (caplacizumab-yhdp) | Form | 8/2/2019 |
| CAPRELSA® (vandetanib) | Form | 8/2/2019 |
| CERDELGA® (eliglustat) capsules, for oral use | Form | 8/2/2019 |
| Cerezyme® (imiglucerase for injection) | Form | 8/2/2019 |
| DAPTACEL® Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed | Form | 8/2/2019 |
| Diphtheria and Tetanus Toxoids Adsorbed | Form | 8/2/2019 |
| DUPIXENT® (dupilumab) Injection | Form | 8/2/2019 |
| ELITEK® (rasburicase) for injection | Form | 8/2/2019 |
| ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein] | Form | 8/2/2019 |
| FABRAZYME® (agalsidase beta) for injection, for intravenous use | Form | 8/2/2019 |
| Flublok® Quadrivalent Influenza Vaccine | Form | 8/2/2019 |
| Fluzone® Quadrivalent Influenza Vaccine | Form | 8/2/2019 |
| Imogam® Rabies - HT Rabies Immune Globulin (Human) USP, Heat Treated | Form | 8/2/2019 |
| Imovax® Rabies Rabies Vaccine (Human Diploid Cell) | Form | 8/2/2019 |
| IPOL® Poliovirus Vaccine Inactivated | Form | 8/2/2019 |
| JEVTANA® (cabazitaxel) Injection | Form | 8/2/2019 |
| KEVZARA® (sarilumab) | Form | 8/2/2019 |
| LANTUS® (insulin glargine injection) | Form | 8/2/2019 |
| LEMTRADA® (alemtuzumab) | Form | 8/2/2019 |
| LIBTAYO® (cemiplimab - rwlc) | Form | 8/2/2019 |
| LUMIZYME® (alglucosidase alfa) | Form | 8/2/2019 |
| Menactra® Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine | Form | 8/2/2019 |
| Mozobil® (plerixafor injection) | Form | 8/2/2019 |
| MULTAQ® (dronedarone) | Form | 8/2/2019 |
| Pentacel® Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine | Form | 8/2/2019 |
| Praluent® (alirocumab) Injection | Form | 8/2/2019 |
| Priftin® (rifapentine) Tablets | Form | 8/2/2019 |
| Primaquine (Phosphate Tablets, USP) | Form | 8/2/2019 |
| Quadracel® Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine | Form | 8/2/2019 |
| SOLIQUA® 100/33 (insulin glargine and lixisenatide injection) | Form | 8/2/2019 |
| SYNVISC® (hylan G-F 20) | Form | 8/2/2019 |
| TENIVAC™ Tetanus and Diphtheria Toxoids Adsorbed | Form | 8/2/2019 |
| Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)] | Form | 8/2/2019 |
| THYROGEN® (thyrotropin alfa for injection) | Form | 8/2/2019 |
| TOUJEO® (insulin glargine injection) U-300 | Form | 8/2/2019 |
| TUBERSOL® (Tuberculin Purified Protein Derivative, Mantoux) | Form | 8/2/2019 |
| Typhim Vi® Typhoid Vi Polysaccharide Vaccine | Form | 8/2/2019 |
| YF-VAX® Yellow Fever Vaccine | Form | 8/2/2019 |
| ZALTRAP® (ziv-aflibercept) Injection for Intravenous Infusion | Form | 8/2/2019 |
House Bill 19-1131. Published by the General Assembly of the State of Colorado
Please See Full Prescribing Information, including Boxed Warning, for Aldurazyme, Aubagio, Avalide, Avapro, Caprelsa, Elitek, Jevtana, Kevzara, Lemtrada, Lumizyme, Multaq, Thymoglobulin, Zaltrap